Centene named Chris Neczypor CFO effective January 1, 2027, succeeding Drew Asher, who steps down December 31 and retires at the end of 2027. The date is the story: Neczypor takes the chair on the first day of a year with no 2025 settlement tailwind, a Medicaid book guided down 8–9%, and post-subsidy-cliff exchange economics. An outside hire from life and annuities reads as a capital-allocation mandate, not an operating one.
Centene (NYSE: CNC) announced on August 17 that Drew Asher will step down as Chief Financial Officer on December 31, 2026 and retire from the company at the end of 2027. Chris Neczypor becomes Executive Vice President and Chief Financial Officer effective January 1, 2027, joining in September to work alongside Asher through the handoff. Asher stays on past the transition to support strategic initiatives through his retirement.
Neczypor arrives from outside healthcare. He was EVP and CFO at Lincoln Financial, which he joined in 2018 and where he also served as Chief Strategy Officer with roles spanning investments, strategic planning and enterprise transformation. Before Lincoln, more than a decade in investment and financial services — equity research at Goldman Sachs, then buy-side roles at institutional asset managers. Life insurance, annuities, group benefits, retirement solutions. Not Medicaid managed care.
Asher's tenure was a scale story and the numbers say so plainly. He took the CFO seat in 2021 with Centene at approximately $126 billion in revenue; the company closed 2025 at approximately $195 billion. That is roughly 11.5% compounded over four years — growth delivered through the largest Medicaid expansion-and-redetermination cycle in the program's history and through an exchange book that went from strategic asset to margin problem and most of the way back.
Q2 2026, reported July 28: adjusted EPS of $2.51, against a consensus near $0.89. Revenue of $53.60 billion. Full-year 2026 adjusted EPS guidance raised to more than $4.80 from more than $3.40.
Now the composition, which is where the CFO transition gets interesting. Approximately $0.50 of that $2.51 came from prior-year settlements: roughly $180 million in 2025 Marketplace risk adjustment and $160 million in Medicare settlements. Management has said those are not expected to recur in 2027. Call it a fifth of the quarter's adjusted EPS with a stated expiration date.
Segment marks:
Marketplace 2026 pretax margin guidance was raised to 4.5% to 5%, characterized as a return to stability after the 2025 turbulence. Medicare Part D pretax margin expectation was lifted to more than 3% from an initial 2% forecast. Medicaid ended the quarter at 12.1 million members with a health benefits ratio of 93.9%, and the composite Medicaid rate forecast moved up to 5% from 4.5% on what management described as constructive state rate conversations.
And the guidance assumption that frames everything Neczypor inherits: year-end 2026 Medicaid membership is guided down 8% to 9% versus year-end 2025, on continued enrollment and eligibility activity.
Stack the calendar against the segment math.
Neczypor takes the chair on the first day of fiscal 2027. That year begins without the roughly $0.50 of settlement benefit booked in Q2 2026. It begins with a Medicaid book already guided down high single digits and with OBBBA eligibility and work-requirement provisions phasing toward meaningful effect. And it begins in the second full plan year after the enhanced premium tax credits expired at the end of 2025 — an event that raised premium payments for subsidized Marketplace enrollees who kept the same plan by an average of 114% in 2026 and drove open enrollment sign-ups down by more than a million year over year.
The competitive field is thinning around that. As of July 30, 2026, seven carriers had announced exits from ACA Marketplaces for plan year 2027 in some or all of their current states, against five announcing new state entries. Cigna will not offer Marketplace plans in any state after the end of 2026, taking roughly 369,000 enrollees in eleven states off the board.
For a company with Centene's exchange concentration, carrier exits cut two ways and the direction is not knowable from the announcement. Displaced enrollees have to land somewhere, and a remaining carrier picks up share. But share picked up from an exiting competitor in a shrinking, post-subsidy risk pool is share of a population that priced itself into a plan under duress. Whether that is accretive depends entirely on 2027 rate adequacy and on where morbidity settles — and the 2027 repricing cycle is being executed by the outgoing CFO for the incoming one to own.
An outside CFO from life and annuities, with a Goldman equity research background and a Chief Strategy Officer stint on the résumé, is not the profile a managed care company hires to squeeze another hundred basis points out of an HBR. That is an operating problem, and operating problems get solved by promoting from inside the segment.
The profile that gets hired instead is the one you bring in for balance sheet and portfolio questions: capital allocation, business-mix reshaping, buyback-versus-deleveraging calls, and how a company with $195 billion of revenue and three government-program books under simultaneous policy pressure decides which of them it wants to be large in. Lincoln Financial is a business defined by managing long-duration liabilities and capital under regulatory constraint. That is a transferable skill set to an insurer facing a multi-year Medicaid step-down.
That reading is inference, not disclosure. Centene's release frames the appointment around strengthening financial performance, optimizing operations and creating long-term shareholder value — standard language that supports several interpretations. The hypothesis is testable on a specific date.
Three things, in order of information value. First, whether the 2027 guidance framework issued around Q4 2026 — Asher's last as CFO — quantifies the settlement roll-off explicitly or buries it in a bridge. Second, the Medicaid HBR trajectory against that 5% composite rate forecast, because 93.9% leaves very little room if state rate actions lag acuity. Third, and most diagnostic: whether Neczypor's first capital allocation communication after January 1 sounds like an operator defending a footprint or an allocator reshaping one.
The handoff is scheduled. The tailwinds are not.
This is analysis, not investment advice. Continuum does not make recommendations to buy or sell securities.
Discover how Addie helps health systems, post-acute providers, and payers improve throughput, reduce avoidable days, and deliver better transitions of care.
Get Started
